Entities›Eurazeo

Investor Dossier

Eurazeo

active

Typeinvestor

Location—

Portfolio (110 investments)

Series A · May 2026

€8.6M

Growth · May 2026

€70.0M

Series A · Oct 2021

€16.3M

Undisclosed · Jan 2021

LEAD

—

Seed · Dec 2021

LEAD

€4.3M

Seed · Jun 2021

€2.5M

Vestiaire Collective

Growth · Mar 2021

€178.0M

Series C · May 2021

LEAD

€80.0M

Series B · Sept 2021

€578.0M

Series C · Mar 2021

€35.0M

Series E · May 2021

€425.0M

Series D · May 2021

€276.0M

Series B · Sept 2021

€68.0M

Series F · Jul 2021

€301.8M

Growth · Jul 2021

€137.2M

Seed · Jun 2021

€15.0M

Series C · Apr 2021

€102.0M

Seed · Oct 2021

€1.4M

Series B · Nov 2021

€15.0M

Seed · Nov 2021

€7.0M

Vestiaire Collective

Growth · Sept 2021

€178.5M

Undisclosed · Mar 2021

LEAD

—

Series D · Oct 2021

€170.0M

Plug In Digital

Series B · Nov 2021

€63.8M

Series B · Sept 2021

LEAD

€26.0M

Series D · Mar 2021

€90.0M

Series A · Oct 2021

€42.5M

Series A · Sept 2021

€12.0M

Series B · Dec 2021

€39.0M

Series A · May 2021

€9.0M

Undisclosed · Mar 2021

LEAD

—

Series F · Jul 2021

€305.0M

Series E · Jan 2020

€125.0M

Series D · Apr 2019

€110.0M

Series B · Nov 2022

LEAD

€60.0M

Seed · Apr 2026

LEAD

€6.0M

Descartes Underwriting

Series B · Jan 2022

€114.0M

Series E · Jan 2022

€254.0M

Series B · Mar 2022

LEAD

€23.0M

Series A · Sept 2022

€12.0M

Series A · Jun 2022

€28.5M

Seed · Jun 2022

€9.5M

Series B · Oct 2022

LEAD

€20.0M

Series B · Oct 2022

€102.8M

Series D · Jan 2022

€486.0M

Series A · Feb 2022

€18.0M

Series C · Feb 2022

€115.0M

Series C · Jan 2022

€250.0M

Series F · Jul 2022

€380.0M

Growth · Dec 2022

€60.0M

Pre Seed · Apr 2022

LEAD

€2.4M

Series D · Jun 2022

€133.0M

Seed · Feb 2022

€4.0M

Series D · Jul 2022

€60.0M

Series C · Jan 2022

€40.0M

Series B · Jan 2022

€30.0M

Series A · Oct 2022

€20.0M

Growth · Jun 2022

LEAD

€80.0M

Series E · Jan 2022

€448.4M

Seed · Feb 2022

€4.0M

ImCheck Therapeutics

Series C · Jun 2022

€96.0M

Series A · May 2022

€13.8M

Series A · Jul 2022

€10.0M

Series A · Jun 2022

€160.0M

Series F · Mar 2022

€500.0M

Growth · Mar 2022

€130.0M

Series A · Nov 2022

€26.0M

Series B · Mar 2022

€20.0M

Growth · Mar 2022

LEAD

€90.0M

Series B · Dec 2023

€29.8M

Series A · Oct 2023

€7.8M

Growth · Mar 2023

LEAD

€30.0M

Million Victories

Series A · Jun 2023

LEAD

€6.0M

Seed · Sept 2023

LEAD

€3.7M

Seed · Mar 2023

€2.0M

Series B · Mar 2023

€19.8M

Etix Everywhere

Growth · Feb 2023

LEAD

€30.0M

Growth · Dec 2023

€15.9M

Series B · Feb 2023

€53.6M

Series D · Mar 2023

€14.6M

Series A · Dec 2024

€38.0M

Series B · Jan 2024

€50.0M

Seed · May 2024

€220.0M

Series B · Jan 2024

€304.0M

Seed · Nov 2024

€3.0M

Seed · Mar 2024

€5.3M

Seed · Apr 2024

LEAD

€5.6M

Undisclosed · Sept 2024

LEAD

€7.0M

Series A · Feb 2024

€13.0M

Undisclosed · Oct 2024

€14.0M

Series B · Jan 2024

LEAD

€16.0M

Oncodesign Services

Other · Jan 2024

LEAD

€22.0M

Series A · Jun 2024

€26.0M

Series A · Jan 2024

€30.0M

Series B · Jun 2024

€468.0M

Seed · Mar 2026

€8.0M

Seed · Mar 2025

€10.0M

Growth · Feb 2026

€42.1M

Seed · Dec 2025

LEAD

€14.0M

Seed · Dec 2025

€60.0M

Diffusely (ex-Meero)

Growth · Oct 2025

€11.0M

Series C · Oct 2025

LEAD

€58.0M

Series B · Sept 2025

€30.0M

Seed · Jun 2025

LEAD

€8.0M

Seed · May 2025

LEAD

€9.7M

Ekoscan Integrity

Growth · Apr 2025

LEAD

€10K

Series B · Mar 2025

€52.0M

Pre Seed · Feb 2025

€5.0M

Series B · Feb 2025

€29.0M

Series B · Feb 2025

LEAD

€26.0M

Links